Virax Biolabs Group Ltd

VRAX21 Jan 2025
Healthcare
$2.2
-0.05 (-4.59%)
Lowest Today
$2.03
Highest Today
$2.22
Today’s Open
$2.2
Prev. Close
$2.18
52 Week High
$7.63
52 Week Low
$0.6
To Invest in Virax Biolabs Group Ltd

Virax Biolabs Group Ltd

Healthcare
VRAX21 Jan 2025
-0.05 (-4.59%)
1M
3M
6M
1Y
5Y
Low
$2.03
Day’s Range
High
$2.22
2.03
52 Week Low
$0.6
52-Week Range
52 Week High
$7.63
0.6
1 Day
-
1 Week
-8.4%
1 month return
+13.54%
3 month return
+32.52%
6 month return
+84.74%
1 Year return
+111.65%
3 Years return
-98.73%
5 Years return
-
10 Years return
-
Institutional Holdings
Renaissance Technologies Corp
3.35
Squarepoint Ops LLC
0.94
UBS Group AG
0.47
Jane Street Group LLC
0.27
Fidelity Nasdaq Composite Index
0.01
Headlands Technologies LLC
0
Citadel Advisors Llc
0
Fundamentals
Market Cap
9.47 mln
PB Ratio
1.09
PE Ratio
0
Enterprise Value
2.56 mln
Total Assets
5.48 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Virax Biolabs Group Limited, a biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom.
Organisation
Virax Biolabs Group Ltd
Employees
17
Industry
Biotechnology
CEO
Mr. James  Foster
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step